NASH WITH FIBROSIS
Clinical trials for NASH WITH FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new NASH WITH FIBROSIS trials appear
Sign up with your email to follow new studies for NASH WITH FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests new drug to halt scarring in fatty liver disease
Disease control Recruiting nowThis large, late-stage study is testing whether the drug efruxifermin can help people with a serious form of fatty liver disease called NASH or MASH, which causes liver inflammation and scarring. It will enroll 1,650 adults with moderate to advanced liver scarring but not full ci…
Matched conditions: NASH WITH FIBROSIS
Phase: PHASE3 • Sponsor: Akero Therapeutics, Inc • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Stitch in time: new procedure aims to reverse fatty liver disease
Disease control Recruiting nowThis study is testing whether a minimally invasive endoscopic procedure to reduce stomach size, combined with lifestyle changes, is better than lifestyle changes alone for treating a serious fatty liver disease called MASH in people with obesity. Researchers will compare the two …
Matched conditions: NASH WITH FIBROSIS
Phase: NA • Sponsor: Pichamol Jirapinyo, MD, MPH • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC